How is the Cg Oncology Inc. today?

The Cg Oncology Inc. today is trading in the down by -1.75% at 25.76.

How has Cg Oncology Inc. performed historically?

The Cg Oncology Inc. is currently trading down -1.75% on an intraday basis in the past week the index rose 6.58%. The index has been down -7.50% in the past quarter and fell -11.08% in the past year. You can view this in the overview section.

What is Cg Oncology Inc. Annual Revenue?

Cg Oncology Inc. Annual Revenue rose 458.33%, in the last year to $1.14 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Cg Oncology Inc. Annual Net Profit?

Cg Oncology Inc. Annual Net Profit fell 81.12% in the last year to $88.04 M. Its sector's average net profit growth for the last fiscal year was -11.04%.

What is Cg Oncology Inc. Price to Earning Ratio?

Cg Oncology Inc. Price to Earning Ratio is -18.6, which is negative.

What is Cg Oncology Inc. Stock Price?

Cg Oncology Inc. Stock Price fell 11.08% and underperformed its sector by 22.63% in the past year.

What is Cg Oncology Inc. Quarterly Revenue?

Cg Oncology Inc. Quarterly Revenue fell 90.17% YoY to $0.05 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Cg Oncology Inc. Quarterly Net profit?

Cg Oncology Inc. Quarterly Net profit fell 103.45% YoY to $34.45 M. Its sector's average net profit growth YoY for the quarter was -212.78%.

What is Cg Oncology Inc. Debt to Equity Ratio?

Cg Oncology Inc. Debt to Equity Ratio is zero as the company is debt-free.

What is Cg Oncology Inc. Return on Equity(ROE)?

Cg Oncology Inc. Return on Equity(ROE) for the last financial year was -28.85%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Cg Oncology Inc. Mutual Fund Holding?

Cg Oncology Inc. Mutual Fund Holding increased by 1.58% in the last quarter to 39.79.

What is Cg Oncology Inc. Institutional Holding?

Cg Oncology Inc. Institutional Holding decreased by 0.51% in the last quarter to 84.15.

Cg Oncology Inc. XNAS: CGON

Cg Oncology Inc. Live Share Price Today, Share Analysis and Chart

Name: Cg Oncology Inc.: Is Infosys Ltd. worth buying?
Item: Cg Oncology Inc.
Rating: 1.26783325
Author: Trendlyne DVM scores

about

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene gre...

25.76 -0.46 (-1.75%)

36.30% Fall from 52W High

530.4K XNAS Volume

XNAS 22 May, 2025 4:18 PM (EDT)

Board Meeting

The next board meeting for Cg Oncology Inc. is on 30 May 2025 for the purpose of CG Oncology Inc First Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

0.3 / 100

Technically Neutral

50.4 / 100

1Yr Price target upside is 132%

9 analysts

Cg Oncology Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Cg Oncology Inc. Live Share Price Today, Share Analysis and Chart

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene gre...

36.30% Fall from 52W High

SWOT Analysis

Cg Oncology Inc. Live Price Chart

Cg Oncology Inc. FAQ

How is Cg Oncology Inc. today?

Cg Oncology Inc. today is trading in the red, and is down by -1.75% at 25.76.

How has Cg Oncology Inc. performed historically?

Cg Oncology Inc. is currently trading down -1.75% on an intraday basis. In the past week the stock rose 6.58%. stock has been down -7.50% in the past quarter and fell -11.08% in the past year. You can view this in the overview section.